About Careers Internship MedBlogs Contact us
New Types of COVID-19-associated Acute Respiratory Distress Syndrome Discovered

New Types of COVID-19-associated Acute Respiratory Distress Syndrome Discovered

Font : A-A+

  • Two distinct phenotypes of COVID-19-associated ARDS that had differences in their responses to disease discovered
  • Patients with the distinct phenotypes are at increased death risk
  • Acute respiratory distress syndrome (ARDS) is a lung condition where the patient suffers from sudden breathlessness

One-fourth of patients hospitalized for the acute respiratory distress syndrome (ARDS) associated with severe COVID-19 infections are prone to have a distinct phenotype (disease presentation) linked to organ dysfunction, blood-clotting abnormalities and greater risk of death than patients with seemingly similar forms of the disease, said Massachusetts General Hospital (MGH) researchers.

Among 263 patients admitted to intensive care units (ICUs) at MGH for respiratory failure due to severe COVID-19 infection, 70 (26.6%) had increased levels of biomarkers in the bloodstream indicating disordered blood clotting, higher inflammation, and organ dysfunction compared with the other patients, report Sylvia Ranjeva MD, PhD, and Lorenzo Berra, MD, investigators in the Department of Anesthesia, Critical Care and Pain Medicine, and their colleagues in that department and Pulmonary and Critical Care Medicine and Respiratory Care at MGH.


Patients with this more severe phenotype had twice the risk of death, despite minimal differences in respiratory mechanics or in the severity of ARDS between the two phenotypes.

Their findings are published in EClinicalMedicine, an open-access journal of The Lancet group.

ARDS is a catch-all term for lung injury that can arise from many different conditions such as pneumonia, severe influenza, trauma, blood infections or inflammation of the pancreas.

The syndrome can be life-threatening and may require patients to be put on mechanical ventilation, but it has been difficult for clinicians to develop effective therapies because of the wide spectrum of causes associated with it.

Pulmonary care experts typically base treatment decisions for patients with ARDS on how their bodies and immune systems respond to disease. Prior studies have suggested that some patients have what is called a "hyperinflammatory" phenotype, because their bodies respond to disease or injury by unleashing a flood of cytokines (proteins released in response to inflammation) and other substances to fight the disease. Several studies have shown that patients with the hyperinflammatory phenotype have about a 20% greater risk for death compared with other patients.

But until now, it has been unclear whether patient responses to ARDS from other causes are the same as responses to ARDS associated with COVID-19, Ranjeva explains.

"The motivation for our work is that if we can identify subsets of patients with different biochemical characteristics, and then those patients respond differently to treatment or have different clinical outcomes, we would be one step closer to a more mechanism-based understanding of ARDS," she says.

Patients with the less common but more serious phenotype could be identified by increases in markers of organ dysfunction (for example, kidney function and cardiac biomarkers) and by increased evidence of blood-clotting dysfunction (coagulopathy).

Their results suggest that disruption of the normal regulation of blood vessels and circulation could be a key feature of critical illness, severe symptoms, and death related to COVID-19 infections, the researchers write.

Source: Eurekalert

Citations   close

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Colleen Fleiss. (2021, April 16). New Types of COVID-19-associated Acute Respiratory Distress Syndrome Discovered. Medindia. Retrieved on May 22, 2022 from https://www.medindia.net/news/healthwatch/new-types-of-covid-19-associated-acute-respiratory-distress-syndrome-types-discovered-200813-1.htm.

  • MLA

    Colleen Fleiss. "New Types of COVID-19-associated Acute Respiratory Distress Syndrome Discovered". Medindia. May 22, 2022. <https://www.medindia.net/news/healthwatch/new-types-of-covid-19-associated-acute-respiratory-distress-syndrome-types-discovered-200813-1.htm>.

  • Chicago

    Colleen Fleiss. "New Types of COVID-19-associated Acute Respiratory Distress Syndrome Discovered". Medindia. https://www.medindia.net/news/healthwatch/new-types-of-covid-19-associated-acute-respiratory-distress-syndrome-types-discovered-200813-1.htm. (accessed May 22, 2022).

  • Harvard

    Colleen Fleiss. 2021. New Types of COVID-19-associated Acute Respiratory Distress Syndrome Discovered. Medindia, viewed May 22, 2022, https://www.medindia.net/news/healthwatch/new-types-of-covid-19-associated-acute-respiratory-distress-syndrome-types-discovered-200813-1.htm.


News A-Z
What's New on Medindia
Prevent Hacking of Medical Devices: FDA Sounds Alarm
Black Water: Benefits and Uses
World Hypertension Day 2022 - Measure Blood Pressure Accurately, Control It, Live Longer!
View all
Recommended Reading
News Archive
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Patent Ductus Arteriosus Asbestosis Respiratory Distress Syndrome Septicemia Meconium Aspiration Syndrome Psychological Defence Mechanisms 

Most Popular on Medindia

Drug - Food Interactions Color Blindness Calculator Post-Nasal Drip Accident and Trauma Care The Essence of Yoga Indian Medical Journals Daily Calorie Requirements Iron Intake Calculator Nutam (400mg) (Piracetam) Calculate Ideal Weight for Infants

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use